can semaglutide make you have diarrhea Why Causes Diarrhea: Understanding GLP-1 Effects on Gut Motility & Digestion Semaglutide Diarrhea: Why It Happens

Click [...] To view or add a comment, sign in $NVO has started a Phase 1 trial for its new obesity drug candidate LX9851, developed with Lexicon Pharmaceuticals The drug is oral and works differently from current GLP-1 treatments, targeting fat metabolism and satiety signals The study will assess safety in overweight and obese patients, with results expected in Q1 2027 Lexicon receives a $10M milestone payment and could earn up to $1B plus royalties if successful #stocks #Investing To view or add a comment, sign in 16,835 followers

P.NascimentoE

The developer did warn consumers about common side effects, like abdominal pain, nausea, vomiting, diarrhea, constipation, and potential risk of pancreatitis, gallbladder issues, dehydration-related kidney problems, thyroid issues, hypoglycemia, suicidal ideation, and allergic reactions

Her research focused on brain aging, specifically how estrogens and reproductive aging influence the aging brain's synapses and mitochondria